{
    "clinical_study": {
        "@rank": "146222", 
        "arm_group": [
            {
                "arm_group_label": "control arm", 
                "arm_group_type": "Active Comparator", 
                "description": "NID2Gy = 50 Gy Swallowing apparatus: standard dose"
            }, 
            {
                "arm_group_label": "Experimental de escalated arm", 
                "arm_group_type": "Experimental", 
                "description": "NID2Gy = 40 Gy Swallowing apparatus: Dmax \u2264 60 Gy at 1 cm Dmax \u2264 50 Gy at 1.5 cm from the GTV or PSTB edge"
            }
        ], 
        "brief_summary": {
            "textblock": "A randomized clinical trial was initiated to investigate whether a reduction of the dose to\n      the elective nodal sites and the swallowing apparatus delivered by IMRT would result in a\n      reduction of acute and late side effects without compromising tumor control."
        }, 
        "brief_title": "Dose De-escalation to the Elective Nodal Sites in Head and Neck Cancer", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Head and Neck Cancer", 
        "condition_browse": {
            "mesh_term": "Head and Neck Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "1. Study hypothesis\n\n           Dose de-escalation in the elective nodal sites and off-target regions of the swallowing\n           apparatus delivered by IMRT does reduce overall rate of late dysphagia and neck\n           fibrosis comparing to the standard dose to the elective nodal sites.\n\n        2. Primary endpoint\n\n           To estimate the difference in overall rate of late dysphagia and neck fibrosis 1 year\n           after the end of radiotherapy in patients receiving dose de-escalation to the elective\n           nodal sites and off-target regions of the swallowing apparatus applying IMRT.\n\n        3. Secondary endpoints\n\n      Local, regional and distant control Recurrence and site of recurrence Overall, disease-free\n      and disease-specific survival Acute toxicity Quality of life"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        oral cavity, oropharynx, hypopharynx and larynx SCC Histolocervical lymph node metastases\n        of unknown primary cancer Primary unresectable tumor and/or patients refused surgery Stage\n        T2-4; T3-4 N0 Tany N1-3 for laryngeal cancer Karnofsky performance status \u226570% Age \u2265 18\n        years old\n\n        Exclusion Criteria:\n\n        Treatment combined with brachytherapy Prior irradiation to the head and neck region\n        History of prior malignancies, except for cured non-melanoma skin cancer, curatively\n        treated in-situ carcinoma of the cervix or other cancer curatively treated and with no\n        evidence of disease at least 5 years Distant metastases Pregnant or lactating women\n        Patient unlikely to comply with the protocol, i.e. uncooperative attitude, inability to\n        return for follow-up visits, and unlikely to complete the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01812486", 
            "org_study_id": "S50809"
        }, 
        "intervention": [
            {
                "arm_group_label": "Experimental de escalated arm", 
                "intervention_name": "dose de escalation", 
                "intervention_type": "Radiation", 
                "other_name": "IMRT"
            }, 
            {
                "arm_group_label": "control arm", 
                "intervention_name": "standard dose", 
                "intervention_type": "Radiation"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 15, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Leuven", 
                    "country": "Belgium", 
                    "zip": "3000"
                }, 
                "name": "University Hospitals UZLeuven"
            }
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "official_title": "Dose De-escalation to the Elective Nodal Sites, the Swallowing Apparatus and Neck Soft Tissues for Head and Neck Cancer: Multi-centre, Randomized Phase III Trial Using Image-guided Intensity-modulated Radiotherapy (IG-IMRT)", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Belgium: Federal Agency for Drugs and Medicinal Devices", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "overall rate of late dysphagia and neck fibrosis", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01812486"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universitaire Ziekenhuizen Leuven", 
            "investigator_full_name": "Dr. Sandra Nuyts", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "locoregional control", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "measure": "Acute dysphagia", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "source": "Universitaire Ziekenhuizen Leuven", 
        "sponsors": {
            "collaborator": {
                "agency": "University Hospital, Ghent", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Universitaire Ziekenhuizen Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}